Head of Small Molecule Discovery
Elanco
About this role
The Head of Small Molecule Discovery at Elanco will lead the identification and development of novel small molecule therapeutics for animal health, driving programs from target validation through candidate selection. The role combines strategic leadership, scientific oversight, and operational execution while mentoring a high-performing discovery team. The position represents Elanco externally and collaborates across functions to advance the R&D pipeline.
Skills
Qualifications
About Elanco
elanco.comAs a global leader in animal health, Elanco provides innovation solutions to improve animal health and wellbeing. Making life better for animals, makes life better.
Recent company news
FinancialContentElanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?
11 hours ago
Simply Wall StWhy Elanco (ELAN) Is Down 8.2% After Guiding Higher 2026 Revenue Despite Ongoing Net Losses
2 days ago
MarketBeatBarrow Hanley Mewhinney & Strauss LLC Sells 2,592,747 Shares of Elanco Animal Health Incorporated $ELAN
1 day ago
Investing.comElanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum
1 day ago
Mirror IndyState quietly scraps plans for expanded White River State Park
1 day ago
About Elanco
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Elanco.
Salary
$197k – $261k
per year
More jobs at Elanco
Similar Jobs
Senior Research Fellow (Small-Molecule Drug Discovery)
Nanyang Technological University
Executive Director, Analytical Development (Small Molecule)
Structure Therapeutics
Scientific Associate Director - PKDM (Small Molecule ADME)
Amgen
Senior Director, Drug Substance (Small Molecule)
Structure Therapeutics
Head of Small Molecule Network Strategy
AstraZeneca
Principal Scientist, Primary Pharmacology
Pfizer